Clinical Research
Copyright ©2005 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Dec 28, 2005; 11(48): 7631-7638
Published online Dec 28, 2005. doi: 10.3748/wjg.v11.i48.7631
Distribution and effects of polymorphic RANTES gene alleles in HIV/HCV coinfection – A prospective cross-sectional study
Golo Ahlenstiel, Agathe Iwan, Jacob Nattermann, Karin Bueren, Jürgen K Rockstroh, Hans H Brackmann, Bernd Kupfer, Olfert Landt, Amnon Peled, Tilman Sauerbruch, Ulrich Spengler, Rainer P Woitas
Golo Ahlenstiel, Agathe Iwan, Jacob Nattermann, Karin Bueren, Jürgen K Rockstroh, Tilman Sauerbruch, Ulrich Spengler, Rainer P Woitas, Department of Internal Medicine 1, University of Bonn, 53105 Bonn, Germany
Hans H Brackmann, Institute of Experimental Hematology, University of Bonn, 53105 Bonn, Germany
Bernd Kupfer, Institute of Medical Microbiology and Immunology, University of Bonn, 53105 Bonn, Germany
Olfert Landt, TIB MOLBIOL Synthesis Laboratory, 12103 Berlin, Germany
Amnon Peled, , Goldyne Savad Institute of Gene Therapy, Hadassah University Hospital, Jerusalem 91120, Israel
Author contributions: All authors contributed equally to the work.
Correspondence to: RP Woitas, Medizinische Klinik u Poliklinik 1, Universitätsklinikum Bonn, Sigmund-Freud-Straße 25, D-53105 Bonn, Germany. rainer.woitas@ukb.uni-bonn.de
Telephone: +49-228-2875507 Fax: +49-228-287-6643
Received: April 1, 2005
Revised: June 13, 2005
Accepted: June 18, 2005
Published online: December 28, 2005
Abstract

AIM: Chemokines and their receptors are crucial for immune responses in HCV and HIV infection. RANTES gene polymorphisms lead to altered gene expression and influence the natural course of HIV infection. Therefore, these mutations may also affect the course of HIV/HCV coinfection.

METHODS: We determined allele frequencies of RANTES-403 (G→A), RANTES-28 (C→G) and RANTES-IN1.1 (T→C) polymorphisms using real-time PCR and hybridization probes in patients with HIV (n = 85), HCV (n = 112), HIV/HCV coinfection (n = 121), and 109 healthy controls. Furthermore, HIV and HCV loads as well as CD4+ and CD8+ cell counts were compared between different RANTES genotypes.

RESULTS: Frequencies of RANTES-403 A, RANTES-28 G and RANTES-IN1.1 C alleles were higher in HIV infected patients than in healthy controls (-403: 28.2% vs 15.1%, P = 0.002; -28: 5.4% vs 2.8%, not significant; IN1.1: 19.0% vs 11.0%, P = 0.038). In HIV/HCV coinfected patients, these RANTES alleles were less frequent than in patients with HIV infection alone (15.4% P = 0.002; 1.7%; P = 0.048; 12.0%; not significant). Frequencies of these alleles were not significantly different between HIV/HCV positive patients, HCV positive patients and healthy controls.

CONCLUSION: All three RANTES polymorphisms showed increased frequencies of the variant allele exclusively in patients with HIV monoinfection. The finding that the frequencies of these alleles remained unaltered in HIV/HCV coinfected patients suggests that HCV coinfection interferes with selection processes associated with these alleles in HIV infection.

Keywords: RANTES polymorphism; HIV/HCV-coinfection; HCV